Thomas F. Ryan Jr., Director at REPLIGEN CORP (RGEN), sold 86,039 shares at $8.96 ($775K) on 2013-05-15, disclosed to the SEC on 2013-05-15.
Open-market sale of $775k RGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.04 | 39,000 | $353K | 45.5% |
| 2 | $9.04 | 15,000 | $136K | 17.5% |
| 3 | $8.93 | 15,000 | $134K | 17.3% |
| 4 | $8.95 | 116 | $1K | 0.1% |
| 5 | $9.05 | 428 | $4K | 0.5% |
| 6 | $9.07 | 1,611 |
| $15K |
| 1.9% |
| 7 | $8.96 | 14,884 | $133K | 17.2% |
| Total | $9.01 avg | 86,039 | $775K | 100% |
| Filing → |
| RGEN | SELL | 2021-08-05 | $195K | — | Filing → |
| RGEN | SELL | 2021-03-04 | $205K | — | Filing → |
| RGEN | SELL | 2020-11-13 | $351K | — | Filing → |